A Prospective Observational Study of clinical use of Imeglimin for type 2 diabetes mellitus
Not Applicable
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000046316
- Lead Sponsor
- Kyoto University Hospital Department of Diabetes, Endocrinology, and Nutrition
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) Allergy against imeglimin 2) Severe ketosis, coma, type 1 diabetes 3) Severe infection, surgery, injury 4) eGFR < 45 mL/min/1.73m2 5) Severe liver dysfunction (Child-Pugh C) 6) Subjects with pregnancy or lactation 7) Use of Insulin 8) Others who medical doctors judge as inappropriate subjects for imeglimin use.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method